Before blaming a COVID vaccine for cytotoxic lesions of the corpus callosum all other differentials must be ruled out
- PMID: 35843986
- PMCID: PMC9288919
- DOI: 10.1007/s00234-022-03022-8
Before blaming a COVID vaccine for cytotoxic lesions of the corpus callosum all other differentials must be ruled out
Keywords: Corpus callosum; SARS-CoV-2; Side effect; Vaccination.
Conflict of interest statement
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment in
-
Response to: "Before blaming a COVID vaccine for cytotoxic lesions of the corpus callosum all other differentials must be ruled out".Neuroradiology. 2022 Nov;64(11):2101-2102. doi: 10.1007/s00234-022-03057-x. Epub 2022 Sep 23. Neuroradiology. 2022. PMID: 36138239 Free PMC article. No abstract available.
Comment on
-
Cytotoxic lesions of the corpus callosum after COVID-19 vaccination.Neuroradiology. 2022 Oct;64(10):2085-2089. doi: 10.1007/s00234-022-03010-y. Epub 2022 Jul 9. Neuroradiology. 2022. PMID: 35809100 Free PMC article.
Similar articles
-
Response to: "Before blaming a COVID vaccine for cytotoxic lesions of the corpus callosum all other differentials must be ruled out".Neuroradiology. 2022 Nov;64(11):2101-2102. doi: 10.1007/s00234-022-03057-x. Epub 2022 Sep 23. Neuroradiology. 2022. PMID: 36138239 Free PMC article. No abstract available.
-
"Reversible cytotoxic lesion of the corpus callosum following SARS-CoV-2 mRNA vaccine administration: a finding to be aware of".Neuroradiol J. 2022 Dec;35(6):758-762. doi: 10.1177/19714009221096825. Epub 2022 Apr 29. Neuroradiol J. 2022. PMID: 35488375 Free PMC article.
-
Cytotoxic lesions of the corpus callosum after COVID-19 vaccination.Neuroradiology. 2022 Oct;64(10):2085-2089. doi: 10.1007/s00234-022-03010-y. Epub 2022 Jul 9. Neuroradiology. 2022. PMID: 35809100 Free PMC article.
-
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877. Eur Rev Med Pharmacol Sci. 2021. PMID: 33629336 Review.
-
Breakthrough SARS-CoV-2 infections after COVID-19 immunization.J Investig Med. 2022 Aug;70(6):1429-1432. doi: 10.1136/jim-2021-002131. Epub 2022 Jun 29. J Investig Med. 2022. PMID: 35768140 Review.
References
-
- Szypowski W, Dębiec A, Świstak J, Nowocień M, Rzepecki P, Możański M, Staszewski J, Stępień A. Case report of cerebral sinus thrombosis related to immune thrombotic thrombocytopenia following administration of ChAdOx1 nCoV-19 for vaccination against COVID-19. Life (Basel) 2022;12(2):168. doi: 10.3390/life12020168. - DOI - PMC - PubMed
-
- Kasai M, Shibata A, Hoshino A, Maegaki Y, Yamanouchi H, Takanashi JI, Yamagata T, Sakuma H, Okumura A, Nagase H, Ishii A, Goto T, Oka A, Mizuguchi M. Epidemiological changes of acute encephalopathy in Japan based on national surveillance for 2014–2017. Brain Dev. 2020;42(7):508–514. doi: 10.1016/j.braindev.2020.04.006. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous